HLA A1-B8 in the background white population is 10%. Gale states that these studies were carried out 'by authors with no special interest in diabetes', but in fact co-author J.A. Burgess was, and still is, a diabetologist.
HLA A1-B8 (-DR3-DQ2) is the classic autoimmune haplotype-associated not only with susceptibility to type 1 diabetes in the non-CRS population but also with other autoimmune diseases such as myasthenia gravis, systemic lupus erythematosus, chronic active hepatitis and coeliac disease-and has been associated with the epidemiology of rubella [4, 5] . The CRS-diabetes-HLA association was confirmed in the New York cohort of 274 patients [6] . In this case, Gale acknowledges the high rate of insulinrequiring diabetes following the rubella epidemic of 1964-1966 in New York, but judges that 'given the interest of the investigators, the sample may have included a disproportionate number of children with diabetes', and, 'ascertainment bias may have contributed to this very high rate, which is otherwise unexplained'. In the context of a critical evaluation of the literature, these statements appear distinctly subjective. The New York data strengthened the association of CRS with type 1 diabetes, because not only was the frequency of HLA DR3 higher in the CRS patients, but also the frequency of HLA DR2, known to be protective against type 1 diabetes in non-CRS populations [7] , was decreased.
Further evidence for an autoimmune mechanism in CRSassociated diabetes comes from other studies not included in the review. These demonstrated that T cell clones from both CRS and non-CRS type 1 diabetic individuals, raised in response to epitopes in the islet autoantigen glutamic acid decarboxylase, reacted to peptides from rubella virus [8] . There are several cogent reasons why CRS could have set the stage for type 2 diabetes. Babies with CRS were 'small for dates' and had a reduced beta cell mass, and may have had persisting rubella virus infection with reduced postnatal beta cell proliferation. Catch-up growth, resulting in a large child, or puberty with increasing body size and insulin resistance leading to a demand for insulin that exceeds supply, may then lead to type 2 diabetes. Moreover, insulin resistance is now a recognised risk factor for type 1 diabetes [9] . Therefore, in the presence of HLA susceptibility genes for type 1 diabetes, the mechanisms leading to type 2 diabetes after CRS could also promote development of type 1 diabetes. In our view, the evidence, although incomplete, indicates that CRS was associated with diabetes across the spectrum of clinical stereotypes.
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